Build to Sell Roadmap — From Invention to Acquisition

The Roadmap for a Strategic Development with a Clear Exit in Mind

Siert Bruins Siert Bruins is the author of this webpage
The roadmap for Build to Sell

Choosing a Build to Sell strategy means you are not trying to build the largest possible company. Instead, the goal is to create something valuable enough that another company wants to acquire it.

That requires a different way of thinking. The focus is not endless growth, but reducing uncertainty: proving that the technology works, validating the market, protecting your intellectual property and building a structure that others can continue to develop.

This roadmap brings together the most important steps involved in turning an invention into a sellable startup. Not every project follows the exact same route, but understanding the sequence behind these decisions can help you avoid expensive mistakes and wasted years.

Phase 1 — Protect the Idea Before You Build

Before investing serious time or money, it is important to understand how your invention can be protected and whether discussing it publicly could damage future opportunities.

Protect Your Invention Before You Share It

In a Build to Sell strategy, intellectual property is often one of the first real assets you create.

how to protect an invention with a patent before building a startup

Before discussing your invention with investors, companies or development partners, it is important to understand how patent protection works. Public disclosure at the wrong moment can destroy future patent opportunities and reduce the value of your technology.

This guide explains the basics of patents, ownership, timing and confidentiality — and why these decisions matter early in a Build to Sell roadmap.

Use Confidentiality Agreements Before Sharing Your Idea

Many inventors lose control over sensitive information long before a startup is formally created.

non disclosure agreement NDA template for inventors and startups

In a Build to Sell strategy, you will often need to discuss your invention with potential partners, developers, investors or manufacturers. Before doing so, it is important to understand when confidentiality agreements make sense — and when they may not be enough.

This guide explains how NDAs work, what they typically contain, and why confidentiality becomes especially important during the early stages of invention development and startup formation. And find a free template.

Phase 2 — Validate the Problem and the Market

Technology alone is rarely enough. A Build to Sell strategy depends on proving that your invention solves a meaningful problem for a clearly identifiable market.

Phase 3 — Build the Smallest Viable Solution

The purpose of an MVP is not to build a finished product, but to reduce uncertainty. In many successful acquisitions, the acquiring company buys validation, expertise and positioning — not a fully mature business.

Phase 4 — Build the Right Team and Company Structure

As the project grows, questions about ownership, technical leadership and decision-making become increasingly important. Many startups encounter serious problems at this stage.

Phase 5 — Finance Development Without Losing Control

Most technology startups require external funding at some stage. The challenge is not only raising capital, but doing so without creating a structure that becomes unattractive to future buyers.

Phase 6 — Position the Startup for Acquisition

A Build to Sell company is designed with a future buyer in mind. Strategic positioning, intellectual property, market validation and technical credibility all influence acquisition potential.

Not Sure Whether Build to Sell Fits Your Goals?

Not every inventor wants to build a company for acquisition. Some prefer licensing, long-term growth, or publishing their work openly. Compare the four different invention strategies to decide which route fits your goals, ambitions and personal situation.

About Siert Bruins

Siert Bruins, PhD

Hello! I'm Siert Bruins, a Dutch entrepreneur and founder of Life2Ledger B.V. . Trained as a Medical Biologist, I hold a PhD in Clinical Diagnostics from the University of Groningen and have over two decades of hands-on experience in innovation at the intersection of universities, hospitals and technology-driven companies.

Throughout my career, I have (co)-founded several life science startups and helped researchers, inventors, and early-stage founders transform their ideas into prototypes, patents, partnerships, and funded projects. My work spans medical device development, clinical validation, startup strategy, and technology transfer. I've guided innovations from the initial sketch to licensing agreements and investment negotiations.

Since 2009, I've run the Dutch version of this site. I launched to provide founders worldwide with practical, experience-based guidance on inventions, patents, valuation and raising startup capital. Today, in Life2Ledger, I also focus on blockchain-based data validation for AI in healthcare — Specifically: how can you be sure that your AI is trained and validated on the correct data, and that this data truly comes from the patient and the device you think it does?

The content on this site is based on my own experience with real startups — real negotiations, real decisions, and real outcomes. Yes, I use tools to support the writing process, but the insights, structure, and conclusions are my own. This is not generic content, but a reflection of what actually happens behind the scenes.

Want to connect? Visit my LinkedIn or follow me on X. Have questions about your startup strategy or patents? Reach out and I'll share practical insights from real-world experience.